Showing results (381-390 of 400) with videos related to

Sort By:
Pageof 40
Journal of Integrative Medicine|February 15, 2021
Early therapeutic interventions of traditional Chinese medicine in COVID-19 patients: A retrospective cohort studyMiao-Yan Shi, Shi-Qi Sun, Wei Zhang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 15, 2025
Double-Stranded RNA Induces Retinal Pigment Epithelium Cell Degeneration and InflammationKyle Bond, Garrett Klokman, YongYao Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2022
IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancerLi-Teng Ong, Wee Chyan Lee, Shijun Ma, et al.
Imeta|June 20, 2024
GutUDB: A comprehensive multiomics database for intestinal diseasesYi Bao, Yaxin Chen, Lizhu Lin, et al.
Gastroenterology|December 30, 2021
N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal CancerShiyan Wang, Shanshan Gao, Yong Zeng, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancerCaleb Cheng, Jing Hu, Rahul Mannan, et al.
Military Medical Research|June 4, 2024
Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectivesXian-Bin Zhang, Yi-Bao Fan, Rui Jing, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
PIKfyve controls dendritic cell function and tumor immunityJae Eun Choi, Yuanyuan Qiao, Ilona Kryczek, et al.
Nature Medicine|October 3, 2017
Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrenceJian Yuan Goh, Min Feng, Wenyu Wang, et al.
Cancer Discovery|November 14, 2024
The UBA1-STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint BlockadeYi Bao, Gabriel Cruz, Yuping Zhang, et al.
Pageof 40